CEFIZOX: CEFTIZOXIME INJECTION.
The CEFTIZOXIME INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAVENOUS, special_features: CONTAINS 1 GRAM CEFTIZOXIME EQUIVALENT G, features_provided: STERILE, primary_container_type: VIAL, protective_storage_feature: MUST BE FROZEN. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-185-3299, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAVENOUS |
| special_features | CONTAINS 1 GRAM CEFTIZOXIME EQUIVALENT G |
| features_provided | STERILE |
| primary_container_type | VIAL |
| supplementary_features | 2GM CEFTIZOMINE EQUIVALENT; 50ML IN BAG W/HANGING DEVICE; PLASTIC; 24 BAGS PER PACKAGE; PREMIXED IN 5% DEXTROXE (D5W); FROZEN; SINGLE DOSE; BAGS W/HANGER STRAP |
| protective_storage_feature | MUST BE FROZEN |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 100.000 MILLILITERS AFTER RECONSTITUTION |
| active_medicament_medicinal_strength | 2.000 GRAMS CEFTIZOXIME EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFTIZOXIME SODIUM STERILE USP 100ML VIAL 10S PG |
| NSN | 6505-01-185-3299 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTIZOXIME SODIUM STERILE USP POWDER FORM 2GM VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.00 GRAMS CEFTIZOXIME EQUIVALENT G |